CVS Health Corp. on Wednesday forecast a 2023 profit below Wall Street estimates, and also announced it agreed to pay about $5 billion over 10 years to resolve thousands of lawsuits accusing its pharmacy chain of mishandling opioid painkillers.
https://www.pharmalive.com/wp-content/uploads/2022/09/ReutersCVSHealth9-6-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-02 12:01:442022-11-02 12:50:17CVS to move members to other Medicare plans after ratings decline
